Cartilage

AlloSource Announces First Patient Enrolled in ProChondrix CR Cartilage Defect Study

Centennial, Colo. — March 20, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced it has enrolled the first patient in a study titled A Prospective, Multi-Center Study Evaluating ProChondrix® CR for the Repair of Focal Articular Cartilage Defects in the Knee. Chondral injuries impact over one million patients across the United States annually and this potentially debilitating condition can cause compromised mobility and a decline in quality of life. AlloSource’s clinical study will evaluate the effectiveness of ProChondrix CR, a fresh cryopreserved osteochondral allograft, when used for cartilage…